Ebola

An Ebola signature

Continuing their pioneering work, a HUG and University of Geneva team has successfully defined a “formula” capable of predicting the efficacy and safety of new Ebola virus vaccines.

By studying the plasma from 115 Genevan volunteers who took part in a clinical trial of a candidate virus in 2015, researchers observed that the concentration of five inflammation markers was sufficient to understand the gist of the immune response to the virus.

This promising formula is a practical and easy-to-use equation: addition of the concentrations of five substances whose activity is controlled by the monocytes – a category of white blood cells known for fighting the Ebola virus in the human body.

Feedback

Was this page helpful ?

Yes

No

How could we make it better ?

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.